Multiple Sclerosis CD49d+CD154+ as Myelin-Specific Lymphocytes Induced During Remyelination

Cells
doi 10.3390/cells9010015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis

eNeuro
MedicineNeuroscience
2018English

Anti-Cd20 Therapy Depletes Activated Myelin-Specific CD8+ T Cells in Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Remyelination in Multiple Sclerosis: Realizing a Long-Standing Challenge

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2015English

Blueprint for the Development of Remyelination Medicines for Multiple Sclerosis

Clinical Neurology
Neurology
2010English

Autoantibodies to Non-Myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis

Journal of Clinical & Cellular Immunology
2013English

Novel Remyelination Strategy for Multiple Sclerosis in the Era of Oligodendrocytopathy

Clinical Neurology
Neurology
2012English

Promoting Myelin Repair and Return of Function in Multiple Sclerosis

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2011English

Human Monoclonal Antibodies Reactive to Oligodendrocytes Promote Remyelination in a Model of Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Virus Specific Antibodies in Multiple Sclerosis.

BMJ
1972English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy